相似文献
1
New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.
J Invest Dermatol. 2021 Sep;141(9):2112-2122.e3. doi: 10.1016/j.jid.2021.02.764. Epub 2021 Jul 22.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
5
An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature.
Medicine (Baltimore). 2015 Nov;94(45):e2030. doi: 10.1097/MD.0000000000002030.
6
Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.
Br J Dermatol. 2025 Jul 17;193(2):250-258. doi: 10.1093/bjd/ljaf147.
7
Comprehensive Insights into Psoriasis: Pathophysiology, An Advanced Exploration of Current Landscape and Future Prospects in "Therapeutic Strategies".
Recent Adv Inflamm Allergy Drug Discov. 2025;19(2):158-172. doi: 10.2174/0127722708300943240724051518.
8
The M2 Macrophages Importance Role in Psoriasis.
Immun Inflamm Dis. 2025 Jun;13(6):e70211. doi: 10.1002/iid3.70211.
9
IFN-κ Is a Rheostat for Development of Psoriasiform Inflammation.
J Invest Dermatol. 2022 Jan;142(1):155-165.e3. doi: 10.1016/j.jid.2021.05.029. Epub 2021 Aug 5.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
引用本文的文献
1
Cooling Blood and Detoxicating Formula Treats Psoriasis Through RHCG-Related Mechanisms.
Int J Genomics. 2025 Jul 9;2025:5132158. doi: 10.1155/ijog/5132158. eCollection 2025.
2
Psoriasis.
Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.
3
Skin 101: Understanding the Fundamentals of Skin Barrier Physiology-Why is This Important for Clinicians?
J Clin Aesthet Dermatol. 2025 Feb;18(2):7-15.
4
Impact of topical and systemic therapy on carotid-intima media thickness in psoriasis.
Arch Dermatol Res. 2025 Jan 18;317(1):286. doi: 10.1007/s00403-025-03818-7.
5
The role of C-reactive protein and genetic predisposition in the risk of psoriasis: results from a national prospective cohort.
BMC Rheumatol. 2024 Dec 21;8(1):72. doi: 10.1186/s41927-024-00450-2.
6
Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.
J Mol Med (Berl). 2024 Oct;102(10):1187-1198. doi: 10.1007/s00109-024-02481-1. Epub 2024 Aug 30.
7
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights.
J Med Chem. 2024 Jul 25;67(14):11597-11621. doi: 10.1021/acs.jmedchem.4c00840. Epub 2024 Jul 16.
8
Caffeine Boosts Weight-Lifting Performance in Rats: A Pilot Study.
Nutrients. 2024 Jun 26;16(13):2022. doi: 10.3390/nu16132022.
9
Psoriasis and Psoriatic Arthritis-Associated Genes, Cytokines, and Human Leukocyte Antigens.
Medicina (Kaunas). 2024 May 16;60(5):815. doi: 10.3390/medicina60050815.
10
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
J Dermatol. 2024 Jun;51(6):779-790. doi: 10.1111/1346-8138.17255. Epub 2024 May 15.
本文引用的文献
1
Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8 T cells in autoimmunity and cancer.
J Allergy Clin Immunol. 2021 Jun;147(6):2370-2380. doi: 10.1016/j.jaci.2020.11.028. Epub 2020 Dec 9.
2
Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis.
Nat Commun. 2020 Sep 21;11(1):4767. doi: 10.1038/s41467-020-18513-6.
3
Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease.
Am J Hum Genet. 2020 Sep 3;107(3):539-543. doi: 10.1016/j.ajhg.2020.06.020. Epub 2020 Aug 5.
4
Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases.
Am J Hum Genet. 2020 Sep 3;107(3):527-538. doi: 10.1016/j.ajhg.2020.07.001. Epub 2020 Aug 5.
5
Animal models of psoriasis-highlights and drawbacks.
J Allergy Clin Immunol. 2021 Feb;147(2):439-455. doi: 10.1016/j.jaci.2020.04.034. Epub 2020 Jun 16.
6
Interaction between microbiota and immunity in health and disease.
Cell Res. 2020 Jun;30(6):492-506. doi: 10.1038/s41422-020-0332-7. Epub 2020 May 20.
7
The Role of Gut Microbiome in Psoriasis: Oral Administration of and Exacerbates Skin Inflammation of Imiquimod-Induced Psoriasis-Like Dermatitis.
Int J Mol Sci. 2020 May 7;21(9):3303. doi: 10.3390/ijms21093303.
8
Traitor or warrior-Treg cells sneaking into the lesions of psoriatic arthritis.
Clin Immunol. 2020 Jun;215:108425. doi: 10.1016/j.clim.2020.108425. Epub 2020 Apr 17.
9
Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study.
J Invest Dermatol. 2020 Nov;140(11):2129-2137. doi: 10.1016/j.jid.2020.03.957. Epub 2020 Apr 10.
10
Recent genetic advances in innate immunity of psoriatic arthritis.
Clin Immunol. 2020 May;214:108405. doi: 10.1016/j.clim.2020.108405. Epub 2020 Apr 2.
Zotero 插件